The global Monoclonal Antibodies market size is expected to reach USD 479.13 billion by 2030, according to a new study by Polaris Market Research. The report “Monoclonal Antibodies Market Share, Size, Trends, Industry Analysis Report, By Source Type (Chimeric, Murine, Humanized, Human), By Production Type (In Vivo, In Vitro), By Application, By End-use, By Region; Segment Forecast, 2022 - 2030” gives a detailed insight into current market dynamics and provides an analysis of future market growth.
The increasing uses of mAb therapies, rising government initiatives in infection control and management, and growing cancer incidences, with the demand for cost-effective biosimilar monoclonal antibodies, are the major factors driving the market. In addition, the high demand for biologics, the expansion of genomics R&D activities, and the introduction of technologically advanced genetic platforms like next-generation sequencing also spur market growth.
Have Questions? Request a sample or make an Inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/monoclonal-antibodies-market/request-for-sample
Furthermore, the monoclonal antibody market has grown due to the COVID-19 virus outbreak. Effective treatments are required due to the sudden increase in individuals with COVID-19 and the mortality risk associated with the illness. Additionally, due to their potential to reduce disease burden, numerous industry participants are consistently working to create novel mAb for the prevention and treatment of the COVID-19 virus. These antibodies are an efficient alternative for decreasing COVID-19, and the US FDA has given emergency use authorizations (EUA) for several of these antibodies.
Monoclonal Antibodies Market Report Highlights
Polaris Market Research has segmented the Monoclonal Antibodies Market report based on raw material, type, technology, end-use, and region:
Monoclonal Antibodies, Source type Outlook (Revenue - USD Billion, 2018 - 2030)
Monoclonal Antibodies, Production Type Outlook (Revenue - USD Billion, 2018 - 2030)
Monoclonal Antibodies Application Outlook (Revenue - USD Billion, 2018 - 2030)
Monoclonal Antibodies, End-Use Outlook (Revenue - USD Billion, 2018 - 2030)
Monoclonal Antibodies, Regional Outlook (Revenue - USD Billion, 2018 - 2030)